Musculoskeletal Disorders Drugs Market by Disorder Type (Rheumatoid Arthritis, Osteoporosis, Osteoarthritis, Psoriatic Arthritis, Fibromyalgia, Ankylosing Spondylitis, and Others), Treatment Type (Medication, Surgery, and Therapy), Route of Administration (Oral, Parenteral, and Others), and Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Drug Store, and Online Pharmacy): Global Opportunity Analysis and Industry Forecast, 2021–2030

Musculoskeletal Disorders Drugs Market Outlook 2030

Musculoskeletal disorder are injuries or pain in the human musculoskeletal system which consists of joints, ligaments, muscles, nerves, tendons, and structures that support limbs. Musculoskeletal can be caused due to sudden exertion such as lifting a heavy object or making same movement repetitive causing strain. Musculoskeletal disorder can lead to improper functionality of joints and muscles. Self-reports, physical examination, and lab tests are used in diagnosis of this disorder. Non-steroidal anti-inflammatory drugs such as aspirin, ibuprofen, & paracetamol, actonel, aldurazyme, salagen, and others are drugs which are used in the treatment of musculoskeletal disorder.

Market Scope and Structure Analysis

COVID-19 Impact Analysis             

COVID-19 is an infectious disease that originated in Hubei province of the Wuhan city in China in late December. The highly contagious disease, caused by a virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is transmitted from human to human. Since the outbreak in December 2019, the disease has spread to almost 213 countries around the globe with the World Health Organization declaring it a public health emergency on March 11, 2020.

Pharmaceutical and biotech companies together with governments around the globe are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicine supply chain challenges. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs such as Hydroxychloroquine have witnessed a dramatic surge in demand for the management of COVID-19. Such high demand for these drugs has presented huge opportunities for manufacturers of COVID-19 management drugs, as many developed countries are facing shortage of these drugs. Thus, the pharmaceutical and biotechnology industry is expected to witness a significant growth in the future owing to the demand for vaccine and treatment drugs for COVID-19. This in turn is expected to have a significant impact on the musculoskeletal disorders drugs market.

Top Impacting Factors

• Increase in prevalence of chronic diseases such as arthritis, rise in cases of accidents across the globe, surge in incidence of sports related injuries, increase in adoption of sedentary & unhealthy lifestyle, rise in geriatric population, and surge in usage of early diagnosis of diseases are the major factors that drive the growth of market.
• In addition, increase in adoption of advance healthcare facilities, rise in number of emergency cases, surge in demand for cost effective treatment, increase in usage of accurate diseases diagnosis, rise in investment on healthcare sector, surge in number of personalized medication, and emerging economies in developing countries are the factors the fuel the growth of market.
• However, side effects related use of musculoskeletal drugs and ignorance for treatment for acute pain hinder the growth of market.
• Contrarily, rise in trauma cases and government support for regulatory approvals are expected to offer lucrative opportunities for the expansion of the market.

Market Trends

New Product Launches to Flourish the Market

In 2020, Lincoln Pharma announced launch of diclofenac spray in Indian market. This spray results in quick pain relief and can be used in treatment of muscle spasm and other problems such as musculoskeletal disorders.

In 2019, Galt Pharmaceuticals announced U.S. Food and Drug Administration approval for launch of Orphengesic Forte. This product contain aspirin, caffeine, and orphenadrine for the treatment of pain caused due to musculoskeletal disorders.

Key Segments

Key Benefits of the Report

• This study presents the analytical depiction of musculoskeletal disorders drugs market industry along with the current trends and future estimations to determine the imminent investment pockets.
• The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the musculoskeletal disorders drugs market share.
• The current market is quantitatively analyzed from 2020 to 2030 to highlight the musculoskeletal disorders drugs market growth scenario.
• Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
• The report provides a detailed market analysis depending on competitive intensity and how the competition will take shape in coming years.

Questions Answered in the Musculoskeletal Disorders Drugs Market Report     

• Which are the leading players active in the musculoskeletal disorders drugs market?
• What are the current trends that will influence the market in the next few years?
• What are the driving factors, restraints, and opportunities of the market?
• What future projections would help in taking further strategic steps?
• What is "musculoskeletal disorders drugs"?
• What is "musculoskeletal disorders drugs" market prediction in the future?
• Who are the leading global players in the "musculoskeletal disorders drugs" market?
• What are the current trends and predicted trends?
• What are the key benefits of the "musculoskeletal disorders drugs" market report?

 Key Market Segments & Key Market Players